NYU Langone Health’s Ronald O. Perelman Department of Dermatology has received a five-year, $11 million NCI grant to design tools that predict whether therapies that help the immune system fight cancer will be effective for a specific patient.
To access this subscriber-only content please log in or renew your subscription.
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe